Related references
Note: Only part of the references are listed.Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
I. Doycheva et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
Raymond Kwok et al.
GUT (2016)
Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study
Edith M. Koehler et al.
HEPATOLOGY (2016)
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus A Randomized Trial
Kenneth Cusi et al.
ANNALS OF INTERNAL MEDICINE (2016)
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
Andrea Marengo et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
Joel T. Haas et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
Romina Lomonaco et al.
DIABETES CARE (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
DIABETOLOGIA (2016)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
The rs2294918 E434K Variant Modulates Patatin-Like Phospholipase Domain-Containing 3 Expression and Liver Damage
Benedetta Donati et al.
HEPATOLOGY (2016)
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
Jeffrey Cui et al.
JOURNAL OF HEPATOLOGY (2016)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Matthew James Armstrong et al.
LANCET (2016)
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants
Bin Zhou et al.
LANCET (2016)
The Relationship of Diabetes and Smoking Status to Hepatocellular Carcinoma Mortality
Chien-Hsieh Chiang et al.
MEDICINE (2016)
Time course of postprandial hepatic phosphorus metabolites in lean, obese, and type 2 diabetes patients
Maria Fritsch et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes
Rachel J. Perry et al.
CELL (2015)
Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis
Chrysi Koliaki et al.
CELL METABOLISM (2015)
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
Aijaz Ahmed et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
Jessica Bazick et al.
DIABETES CARE (2015)
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Amedeo Lonardo et al.
DIGESTIVE AND LIVER DISEASE (2015)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Guillaume Lassailly et al.
GASTROENTEROLOGY (2015)
Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis
Siddharth Singh et al.
HEPATOLOGY (2015)
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
Paola Portillo-Sanchez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver
Santhosh Satapati et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2
You Zhou et al.
JOURNAL OF HEPATOLOGY (2015)
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
Stuart McPherson et al.
JOURNAL OF HEPATOLOGY (2015)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Current efforts and trends in the treatment of NASH
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2015)
Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
Rachel J. Perry et al.
SCIENCE (2015)
Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo
Paul M. Titchenell et al.
NATURE COMMUNICATIONS (2015)
Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases
Evan J. Raff et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2015)
Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients
George Boon-Bee Goh et al.
BBA CLINICAL (2015)
Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease A 5-Year Controlled Longitudinal Study
Robert Caiazzo et al.
ANNALS OF SURGERY (2014)
Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria
Willi Oberaigner et al.
BMC PUBLIC HEALTH (2014)
Lower Fasting Muscle Mitochondrial Activity Relates to Hepatic Steatosis in Humans
Julia Szendroedi et al.
DIABETES CARE (2014)
GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetes
Bertrand Cariou et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Pathological Features of Fatty Liver Disease
Matthew M. Yeh et al.
GASTROENTEROLOGY (2014)
Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
Jennifer E. Lambert et al.
GASTROENTEROLOGY (2014)
Inflammatory and Metabolic Biomarkers and Risk of Liver and Biliary Tract Cancer
Krasimira Aleksandrova et al.
HEPATOLOGY (2014)
Extrahepatic Complications of Nonalcoholic Fatty Liver Disease
Matthew J. Armstrong et al.
HEPATOLOGY (2014)
A population-based study on the prevalence of NASH using scores validated against liver histology
Jenni Hyysalo et al.
JOURNAL OF HEPATOLOGY (2014)
Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: The Edinburgh type 2 diabetes study
Joanne R. Morling et al.
JOURNAL OF HEPATOLOGY (2014)
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
Jessica Dyson et al.
JOURNAL OF HEPATOLOGY (2014)
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
Julia Kozlitina et al.
NATURE GENETICS (2014)
Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
Gerald I. Shulman
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans
Julia Szendroedi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors
Rebecca A. Haeusler et al.
NATURE COMMUNICATIONS (2014)
Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
Norbert Stefan et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Hannele Yki-Jarvinen
LANCET DIABETES & ENDOCRINOLOGY (2014)
Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
Tania M. Welzel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Inflammation, Cytokines and Insulin Resistance: A Clinical Perspective
Verena Wieser et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2013)
The Origins and Drivers of Insulin Resistance
Andrew M. F. Johnson et al.
CELL (2013)
Immunological Goings-on in Visceral Adipose Tissue
Diane Mathis
CELL METABOLISM (2013)
Adipocyte Lipid Chaperone aP2 Is a Secreted Adipokine Regulating Hepatic Glucose Production
Haiming Cao et al.
CELL METABOLISM (2013)
Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes
E. Phielix et al.
DIABETES OBESITY & METABOLISM (2013)
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
Barbara Fruci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Resolution of Fatty Liver and Risk of Incident Diabetes
Ki-Chul Sung et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes
Iliana Doycheva et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2013)
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
Raluca Pais et al.
JOURNAL OF HEPATOLOGY (2013)
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
Miki Okada-Iwabu et al.
NATURE (2013)
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus
Stefan Kiechl et al.
NATURE MEDICINE (2013)
Noninvasive evaluation of NAFLD
Laurent Castera et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
From NAFLD to NASH to cirrhosis - new insights into disease mechanisms
Alexander Wree et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
Monica Franciosi et al.
PLOS ONE (2013)
Diabetes Mellitus Is Associated with Hepatocellular Carcinoma: A Retrospective Case-Control Study in Hepatitis Endemic Area
Ze Zheng et al.
PLOS ONE (2013)
Non-alcoholic steatohepatitis: a microbiota-driven disease
Alexander R. Moschen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
Melania Gaggini et al.
NUTRIENTS (2013)
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Varman T. Samuel et al.
CELL (2012)
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
G. Musso et al.
DIABETOLOGIA (2012)
Intrahepatic Diacylglycerol Content Is Associated With Hepatic Insulin Resistance in Obese Subjects
Faidon Magkos et al.
GASTROENTEROLOGY (2012)
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis
Rohit Loomba et al.
HEPATOLOGY (2012)
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
Romina Lomonaco et al.
HEPATOLOGY (2012)
Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1
Mingjian Lu et al.
NATURE MEDICINE (2012)
Mitochondria and Redox Signaling in Steatohepatitis
E. Matthew Morris et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma
Kohichiroh Yasui et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression
Hisataka Goto et al.
CYTOKINE (2011)
Subcutaneous Adipose Tissue Macrophage Infiltration Is Associated With Hepatic and Visceral Fat Deposition, Hyperinsulinemia, and Stimulation of NF-κB Stress Pathway
Kim-Anne Le et al.
DIABETES (2011)
Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes
Albrecht Ingo Schmid et al.
DIABETES CARE (2011)
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Christopher D. Williams et al.
GASTROENTEROLOGY (2011)
Apolipoprotein CIII Overexpressing Mice Are Predisposed to Diet-Induced Hepatic Steatosis and Hepatic Insulin Resistance
Hui-Young Lee et al.
HEPATOLOGY (2011)
Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Losartan in the Treatment of Nonalcoholic Steatohepatitis in Humans: A 12-Month Randomized, Prospective, Open-Label Trial
Dawn M. Torres et al.
HEPATOLOGY (2011)
Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents The TONIC Randomized Controlled Trial
Joel E. Lavine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Adipose and Liver Expression of Interleukin (IL)-1 Family Members in Morbid Obesity and Effects of Weight Loss
Alexander R. Moschen et al.
MOLECULAR MEDICINE (2011)
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Naoki Kumashiro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact
Esther Phielix et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study
Leon A. Adams et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Dissociation Between Intrahepatic Triglyceride Content and Insulin Resistance in Familial Hypobetalipoproteinemia
Anastassia Amaro et al.
GASTROENTEROLOGY (2010)
Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor α expression
Alexander R. Moschen et al.
GUT (2010)
Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (FLIRT 2) Extension Trial
Vlad Ratziu et al.
HEPATOLOGY (2010)
Liver Enzymes, Nonalcoholic Fatty Liver Disease, and Incident Cardiovascular Disease: A Narrative Review and Clinical Perspective of Prospective Data
Nazim Ghouri et al.
HEPATOLOGY (2010)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis
Shaoqing He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Insulin Resistance is the Best Predictor of the Metabolic Syndrome in Subjects With a First-Degree Relative With Type 2 Diabetes
Kristina M. Utzschneider et al.
OBESITY (2010)
Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Noreen Hossain et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Alanine Aminotransferase, γ-Glutamyltransferase, and Incident Diabetes
Abigail Fraser et al.
DIABETES CARE (2009)
Abnormal Hepatic Energy Homeostasis in Type 2 Diabetes
Julia Szendroedi et al.
HEPATOLOGY (2009)
Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
Nathalie C. Leite et al.
LIVER INTERNATIONAL (2009)
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
John Willy Haukeland et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial
William W. Shields et al.
Therapeutic Advances in Gastroenterology (2009)
Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet
Caroline Romestaing et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Rosiglitazone for nonalcoholic steatohepatitis: One-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) trial
Vlad Ratziu et al.
GASTROENTEROLOGY (2008)
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
Guruprasad P. Aithal et al.
GASTROENTEROLOGY (2008)
Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
Wolfram Goessling et al.
GASTROENTEROLOGY (2008)
Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease
Elisa Fabbrini et al.
GASTROENTEROLOGY (2008)
Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury
G. Serviddio et al.
GUT (2008)
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
Anna Ludovica Fracanzani et al.
HEPATOLOGY (2008)
Inflammatory mechanisms in the regulation of insulin resistance
Herbert Tilg et al.
MOLECULAR MEDICINE (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Quantitative ATP synthesis in human liver measured by localized 31P spectroscopy using the magnetization transfer experiment
A. I. Schmid et al.
NMR IN BIOMEDICINE (2008)
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients
G. Targher et al.
DIABETOLOGIA (2008)
Liver fat in the metabolic syndrome
Anna Kotronen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Endocrine regulation of energy metabolism by the skeleton
Na Kyung Lee et al.
CELL (2007)
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
Kitt Falk Petersen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
Giovanni Targher et al.
DIABETES CARE (2007)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
Mechanisms of Disease: hepatic steatosis in type 2 diabetes - pathogenesis and clinical relevance
Michael Roden
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2006)
Liver markers and development of the metabolic syndrome - The insulin resistance atherosclerosis study
AJG Hanley et al.
DIABETES (2005)
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease
E Bugianesi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
DS Cai et al.
NATURE MEDICINE (2005)
IKK-β links inflammation to obesity-induced insulin resistance
MC Arkan et al.
NATURE MEDICINE (2005)
Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease
GA Abrams et al.
HEPATOLOGY (2004)
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
VT Samuel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes
M Krssak et al.
DIABETES (2004)
Defective liver disposal of free fatty acids in patients with impaired glucose tolerance
P Iozzo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Gamma-glutamyltransferase and diabetes - a 4 year follow-up study
DH Lee et al.
DIABETOLOGIA (2003)
Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma
E Bugianesi et al.
GASTROENTEROLOGY (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ
MS Yuan et al.
SCIENCE (2001)
Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
G Marchesini et al.
DIABETES (2001)
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
AJ Sanyal et al.
GASTROENTEROLOGY (2001)
Mechanisms of disease: Cytokines in alcoholic and nonalcoholic steatohepatitis.
H Tilg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
A Poonawala et al.
HEPATOLOGY (2000)
Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans
M Roden et al.
DIABETES (2000)
Share Paper
